ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
BeyondSpring Inc

BeyondSpring Inc (BYSI)

1.6607
-0.0293
(-1.73%)
At close: December 26 4:00PM
1.6607
0.00
( 0.00% )
After Hours: 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.6607
Bid
1.65
Ask
1.71
Volume
6,263
1.62 Day's Range 1.71
0.7777 52 Week Range 4.00
Market Cap
Previous Close
1.69
Open
1.62
Last Trade
1
@
1.68
Last Trade Time
16:00:00
Financial Volume
$ 10,597
VWAP
1.692
Average Volume (3m)
26,025
Shares Outstanding
39,029,163
Dividend Yield
-
PE Ratio
-3.08
Earnings Per Share (EPS)
-0.54
Revenue
1.75M
Net Profit
-21.03M

About BeyondSpring Inc

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
New York, New York, USA
Founded
-
BeyondSpring Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BYSI. The last closing price for BeyondSpring was $1.69. Over the last year, BeyondSpring shares have traded in a share price range of $ 0.7777 to $ 4.00.

BeyondSpring currently has 39,029,163 shares outstanding. The market capitalization of BeyondSpring is $65.96 million. BeyondSpring has a price to earnings ratio (PE ratio) of -3.08.

BYSI Latest News

BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting

FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (β€œBeyondSpring” or the β€œCompany”), a clinical-stage global biopharmaceutical company developing innovative...

BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024

FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (β€œBeyondSpring” or the β€œCompany”), a clinical-stage global biopharmaceutical company developing innovative...

BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plinabulin Showcasing Positive Final Phase 3 Data in 2L/3L NSCLC EGFR Wild-Type with Concurrent Publication in the Lancet Respiratory Medici

- Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC...

BeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, Plinabulin

FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (β€œBeyondSpring” or the β€œCompany”), a clinical-stage global biopharmaceutical company focused on developing...

SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications

The SEED-Eisai Research Collaboration leverages Eisai’s leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.11077.141935483871.551.751.43425721.60124629CS
4-0.2393-12.59473684211.91.941.43347591.63787164CS
12-0.8693-34.35968379452.532.53121.43260251.86955176CS
26-0.7693-31.6584362142.432.61.43258462.01266391CS
520.8307100.0843373490.8340.7777831472.53888405CS
156-3.2393-66.10816326534.95.1750.5422356442.22906109CS
260-13.3793-88.958111702115.04330.54245611813.1475555CS

BYSI - Frequently Asked Questions (FAQ)

What is the current BeyondSpring share price?
The current share price of BeyondSpring is $ 1.6607
How many BeyondSpring shares are in issue?
BeyondSpring has 39,029,163 shares in issue
What is the market cap of BeyondSpring?
The market capitalisation of BeyondSpring is USD 65.96M
What is the 1 year trading range for BeyondSpring share price?
BeyondSpring has traded in the range of $ 0.7777 to $ 4.00 during the past year
What is the PE ratio of BeyondSpring?
The price to earnings ratio of BeyondSpring is -3.08
What is the cash to sales ratio of BeyondSpring?
The cash to sales ratio of BeyondSpring is 36.97
What is the reporting currency for BeyondSpring?
BeyondSpring reports financial results in USD
What is the latest annual turnover for BeyondSpring?
The latest annual turnover of BeyondSpring is USD 1.75M
What is the latest annual profit for BeyondSpring?
The latest annual profit of BeyondSpring is USD -21.03M
What is the registered address of BeyondSpring?
The registered address for BeyondSpring is 28 LIBERTY STREET, 39TH FLOOR, NEW YORK, NEW YORK, 10005
What is the BeyondSpring website address?
The website address for BeyondSpring is www.beyondspringpharma.com
Which industry sector does BeyondSpring operate in?
BeyondSpring operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EVAXEvaxion Biotech AS
$ 1.8701
(121.05%)
6.04M
KITTNauticus Robotics Inc
$ 2.4601
(38.21%)
1.03M
OMEXOdyssey Marine Exploration Inc
$ 0.6466
(34.57%)
8.33M
LIDRAEye Inc
$ 1.58
(23.44%)
327.14k
CRKNCrown Electrokinetics Corporation
$ 0.1619
(22.93%)
17.29M
VIRXViracta Therapeutics Inc
$ 0.20
(-15.61%)
270.39k
XELBXcel Brands Inc
$ 0.4446
(-14.32%)
22.49k
RAYRaytech Holding Ltd
$ 1.39
(-12.03%)
10.86k
SLGLSol Gel Technologies Ltd
$ 1.08
(-11.48%)
24.18k
LKCOLuokung Technology Corporation
$ 1.67
(-10.22%)
9.38k
CRKNCrown Electrokinetics Corporation
$ 0.16
(21.49%)
17.31M
OMEXOdyssey Marine Exploration Inc
$ 0.6401
(33.22%)
8.33M
EVAXEvaxion Biotech AS
$ 1.8701
(121.05%)
6.04M
RGTIRigetti Computing Inc
$ 15.3499
(-0.58%)
3.14M
XTIAXTI Aerospace Inc
$ 0.04035
(0.88%)
3.12M

BYSI Discussion

View Posts
Monksdream Monksdream 6 months ago
BYSI 10Q expected Monday 6/24
πŸ‘οΈ0
glenn1919 glenn1919 7 months ago
BYSI.................................https://stockcharts.com/h-sc/ui?s=BYSI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
BYSI under $5
πŸ‘οΈ0
glenn1919 glenn1919 10 months ago
BYSI..........................................https://stockcharts.com/h-sc/ui?s=BYSI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BYSI new 52 week high
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BYSI new 52 week high
πŸ‘οΈ0
glenn1919 glenn1919 10 months ago
BYSI................................https://stockcharts.com/h-sc/ui?s=BYSI&p=D&yr=0&mn=2&dy=12&id=p84071410134
πŸ‘οΈ0
Monksdream Monksdream 10 months ago
BYSI under $2
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=BYSI&p=d
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$BYSI: And shes back now................ $1.10

BOOOOOOOOOommmmmmmmmmmmmmmm


HELLO.............. nice to be on the win side here again



GO $BYSI
πŸ‘οΈ0
Montanore Montanore 3 years ago
Nice green pop here today on a down day for the market.
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
News is Great!!!!!$$$$$$$$$$ 25.00 to 48.00
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
Your not kidding $
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
Wow I say Merry Christmas $$$$$$
45.00 65.00 let’s go!!!!
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
That'd be right up my alley treat them all like 000..
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 years ago
You think ? .000001
πŸ‘οΈ0
Montanore Montanore 3 years ago
Egad, what a disaster.

But maybe worth picking up some bargain shares here...
πŸ‘οΈ0
Longer Than Most Longer Than Most 3 years ago
BYSI lotto sub 6
πŸ‘οΈ0
JackAskSlap JackAskSlap 3 years ago
Overreactions easiest money on the planet
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
$6^ bouncing some
πŸ‘οΈ0
saigai saigai 3 years ago
damn sesn all over again. but i dodged this one got sluaghtered on sesn
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
$5 *FAIL* https://ih.advfn.com/stock-market/NASDAQ/beyondspring-BYSI/stock-news/86697907/beyondspring-fails-to-win-fda-approval-for-plinabu
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
https://ih.advfn.com/stock-market/NASDAQ/beyondspring-BYSI/stock-news/86697835/report-of-foreign-issuer-pursuant-to-rule-13a-16-o
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
In September, BeyondSpring tanked after the company gave investors a closer look at Dublin-3 data. In a nutshell, the treatment might not be any more effective than existing options.

Recent lung cancer data was a little disappointing, but investors may be missing the point here. Plinabulin isn't intended to fight cancer directly. It's meant to stop toxic chemotherapy from destroying white blood cells. A lack of white blood cells, or neutropenia, is a dangerous complication that frequently interrupts chemotherapy treatment.

On or before Nov. 30, 2021, the FDA is expected to issue an approval decision for BeyondSpring's lead candidate plinabulin. If given a green light to treat chemotherapy-induced neutropenia, it could become an important new treatment for lots of different cancer patients.

Message in reply to:

BeyondSpring To Present Final Phase 3 DUBLIN-3 Data With Plinabulin/Docetaxel Combination Versus Docetaxel Alone In 2nd/3rd Line Non-Small Cell Lung Cancer Patients With EGFR Wild Type At European Society for Medical Oncology 2021 Congress Sept. 16-21
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
BYSI 13.50 HALTED UP ^^ PENDING NEWS))))))))))
πŸ‘οΈ0
alvaroc2 alvaroc2 3 years ago
I Was in at 26$, what price target do you have crudeoil? Thanks in advance
πŸ‘οΈ0
cjstocksup cjstocksup 3 years ago
We had a great day today new highs $33.00.
BYSI
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
33.00 > 52 wk. high!
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
BeyondSpring To Present Final Phase 3 DUBLIN-3 Data With Plinabulin/Docetaxel Combination Versus Docetaxel Alone In 2nd/3rd Line Non-Small Cell Lung Cancer Patients With EGFR Wild Type At European Society for Medical Oncology 2021 Congress Sept. 16-21
πŸ‘οΈ0
cjstocksup cjstocksup 3 years ago
I know I love it.
πŸ‘οΈ0
makinezmoney makinezmoney 3 years ago
$BYSI: Now nicely over $31


This thing is gonna go muchhhhhhhhhhhhhhh higher



That NEWS relase 3wks ago was SUPER SOLID



GO BYSI
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
The agreement with Jiangsu Hengrui is in the Greater China area for BeyondSpring's investigational drug candidate plinabulin. Plinabulin in combination with G-CSF is currently under review by the U.S. Food and Drug Administration and the China National Medical Products Administration to prevent chemotherapy-induced neutropenia. The territory for the agreement includes mainland China, Hong Kong, Macau and Taiwan.
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Exactly, on our way to $100.

$BYSI: Monster news....... Monster UPGRADE to $100 by Wainwright

No wonder its on a roll right now


This could be the next $SAVA big time mover



GO $BYSI
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
BYSI moving on a co-development and commercialization agreement for chemotherapy-induced neutropenia treatment candidate.
BeyondSpring shares are trading higher after the company announced an exclusive commercialization and co-development agreement with Jiangsu Hengrui for Plinabulin in Greater China.
πŸ‘οΈ0
cjstocksup cjstocksup 3 years ago
Told everyone to be patient. We hit new 52 week highs today.
BYSI
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
No Sir
πŸ‘οΈ0
Actualfactual Actualfactual 3 years ago
Wow. Hope you held
πŸ‘οΈ0
saigai saigai 3 years ago
for many people the news helps to lessen the fear of any need for an offerring beyond june 22...more money flow..we'll see
πŸ‘οΈ0
Montanore Montanore 3 years ago
Bought some of this dip today--hard not to.
πŸ‘οΈ0
Actualfactual Actualfactual 3 years ago
By the way the market looks it’s not beasting today
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
$BYSI I jumped back in today at $20.20. Have to swing trade this can’t sell tomorrow hope doesn’t pop today
πŸ‘οΈ0
Actualfactual Actualfactual 3 years ago
I dunno about it breaking $20..
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
Load up BYSI going to the moon!
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
Averaging down Jesus!
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
$BYSI back in for a quick flip
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
Wonder if this will ever bottom out? You would think cancer treatments would run. I would jump back in but volume has dried up folks lost interest. Government should ban medical stocks from being shorted. Sad companies try help sick people and some A-hole comes along trying push company’s price down.
πŸ‘οΈ0
BoilerRoom BoilerRoom 3 years ago
$BYSI dumped this for a loss made my money back on NSAV
πŸ‘οΈ0
cjstocksup cjstocksup 3 years ago
All he was showing was his bet's. Means nothing really. I see many people post their puts and calls all day there.
πŸ‘οΈ0
saigai saigai 3 years ago
not registered there ..thanks for the consideration..just wondering if it was a bullish sign or not.. i dont understand that part of the game.gl got 2k shares here started buying at 22. love the biotech ....clsd... gltu
πŸ‘οΈ0
cjstocksup cjstocksup 3 years ago
I do not use options I buy stocks. The kids do but I never ask them I have way too much to do even with stocks, alt coins etc. Ask him what he means.
JarvisAlerts
03:00 PM
$BYSI 22.5P Exp:15-Oct-21 ?? ?? Total(Day): $119,151
#SmartMoneyFlow
charts: courtesy of finviz
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock